Unranked
JAZZ
$237.88
-0.91% (24h)
Last updated: 1 second ago
Market Cap
$14.93B
Volume (24h)
66.44K
Last Close (7D)
$237.88
An Ireland-based specialty biopharmaceutical company that makes Epidiolex — the world's first FDA-approved cannabis-derived prescription medicine — alongside a broader CNS, sleep, and oncology drug portfolio.
52-Week Range
ChartMill · 4h ago
Jazz Pharmaceuticals (NASDAQ:JAZZ) Flashes Perfect Minervini Trend Template Score with 116% Annual Surge
Yahoo · 22h ago
Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report?
Benzinga · Feb 14, 2018
8 Stocks Moving In Wednesday's After-Hours Session
Yahoo · Jun 4, 2026
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia
Benzinga · Jun 4, 2026
Jazz Pharmaceuticals To Present 21 Abstracts At SLEEP
SeekingAlpha · Jun 3, 2026
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
